Resources

In the NCQA Commercial Health Plan Ratings 2023, our commercial plan is rated 5 out of 5, the highest rating in the region.

In the NCQA Medicare Health Plan Ratings 2023, our Medicare plan is rated 4.5 out of 5, the highest rating in Maryland, Virginia, and Washington, DC.

The source for certain health plan measure rates and benchmark (averages and percentiles) data (“the Data”) is Quality Compass® 2023 and is used with the permission of the National Committee for Quality Assurance (“NCQA”). Any analysis, interpretation or conclusion based on the Data is solely that of the authors, and NCQA specifically disclaims responsibility for any such analysis, interpretation or conclusion. Quality Compass is a registered trademark of NCQA. The Data comprises audited performance rates and associated benchmarks for Healthcare Effectiveness Data and Information Set measures (“HEDIS®”) and HEDIS CAHPS® survey measure results. HEDIS measures and specifications were developed by and are owned by NCQA. HEDIS measures and specifications are not clinical guidelines and do not establish standards of medical care. NCQA makes no representations, warranties or endorsement about the quality of any organization or clinician who uses or reports performance measures, or any data or rates calculated using HEDIS measures and specifications, and NCQA has no liability to anyone who relies on such measures or specifications. NCQA holds a copyright in Quality Compass and the Data and may rescind or alter the Data at any time. The Data may not be modified by anyone other than NCQA. Anyone desiring to use or reproduce the Data without modification for an internal, noncommercial purpose may do so without obtaining approval from NCQA. All other uses, including a commercial use and/or external reproduction, distribution or publication, must be approved by NCQA and are subject to a license at the discretion of NCQA. 2023 National Committee for Quality Assurance, all rights reserved. CAHPS is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ). Official plan name per Quality Compass: Kaiser Foundation Health Plan of the Mid-Atlantic States, Inc.

Seely J.M. and Alhassan T., “Screening for breast cancer in 2018—what should we be doing today?” Curr Oncol, 2018.

The American Cancer Society Guidelines for the Prevention and Early Detection of Cervical Cancer,” The American Cancer Society.

When appropriate and available. If you travel out of state, phone appointments and video visits may not be available in select states due to licensing laws. Laws differ by state.

KPMAS patients have a higher survival rate compared to the SEER 18 database for black and white races. Cause specific survival rate is based on breast cancer being listed as the underlying cause of death, as per data collected from the National Death Index (NDI).

National benchmark = 2016 National CDC Breast Cancer Mortality vs 2016 KPMAS Population Breast Cancer Mortality (Crude Mortality Rate – Sex Female Only).

National benchmark = 2016 National CDC Colorectal Cancer Mortality vs 2016 KPMAS Population Colorectal Cancer Mortality (Crude Mortality Rate).

KPMAS diabetes patients have a lower mortality rate compared to national CDC metrics.

National benchmark = 2016 National CDC Hypertension Mortality vs 2016 KPMAS Population Hypertension Mortality (Crude Mortality Rate – Sex).